| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/EUHJ.1999.1987 |
| P698 | PubMed publication ID | 10924298 |
| P50 | author | Gerald Maurer | Q47504475 |
| P2093 | author name string | Huber K | |
| Probst P | |||
| Glogar D | |||
| Hornykewycz S | |||
| Nikfardjam M | |||
| Zorn G | |||
| Gottsauner-Wolf M | |||
| Wexberg P | |||
| Stepan E | |||
| Zasmeta G | |||
| P433 | issue | 14 | |
| P304 | page(s) | 1152-1158 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Plasma levels of C-reactive protein after coronary stent implantation | |
| P478 | volume | 21 |
| Q51729364 | C-reactive protein and myocardial infarction during percutaneous coronary intervention. |
| Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
| Q36428114 | Changes in anti-heat shock protein 27 antibody and C-reactive protein levels following cardiac surgery and their association with cardiac function in patients with cardiovascular disease |
| Q28218124 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease |
| Q51132744 | Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation. |
| Q51842730 | Comparison of effects of a thrombin-based femoral artery closure device with those of a mechanical compression device on serum C-reactive protein and amyloid A after percutaneous coronary intervention. |
| Q51812873 | Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting |
| Q35932082 | Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease. |
| Q28219483 | Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease |
| Q35190217 | Current status of intravascular stents as delivery devices to prevent restenosis |
| Q79248847 | Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina |
| Q43013493 | Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention |
| Q37941867 | Do statins have a role in reduction/prevention of post-PCI restenosis? |
| Q51401456 | Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents? |
| Q46663848 | Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention |
| Q34973446 | High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment |
| Q33693147 | Impact of C-reactive protein on in-stent restenosis: a meta-analysis |
| Q57136141 | Impact of Omega-3 Supplementation on High Sensitive C-Reactive Protein Level and 30-Day Major Adverse Cardiac Events After the Implementation of Coronary Stent in Patients with Chronic Kidney Disease: A Randomized Clinical Study |
| Q51808544 | Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response |
| Q51613344 | Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis. |
| Q37923226 | Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies |
| Q36251197 | Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective |
| Q37869481 | Late T-lymphocyte and monocyte activation in coronary restenosis. Evidence for a persistent inflammatory/immune mechanism? |
| Q44346890 | Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization |
| Q51103185 | Osteoprotegerin is not associated with angiographic coronary calcification. |
| Q36263844 | Peri-procedural myocardial injury: 2005 update |
| Q47949365 | Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease |
| Q51370943 | Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. |
| Q28213720 | Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication |
| Q28548500 | Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation |
| Q34694726 | Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation |
| Q28166927 | Role of C-reactive protein in cardiovascular disease |
| Q54655905 | Serum inflammatory and immune marker response after bare-metal or drug-eluting stent implantation following percutaneous coronary intervention. |
| Q53273061 | Stenting in superficial femoral artery and usCRP: Multicentric study SAFE in 255 patients |
| Q51385693 | Systemic inflammation after drug-eluting stent placement. |
| Q46405581 | The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL. |
| Q46561053 | The effects of prior beta-blocker therapy on serum C-reactive protein levels after percutaneous coronary intervention. |
| Q48288451 | Total sleep deprivation augments balloon angioplasty-induced neointimal hyperplasia in rats |
Search more.